Loading clinical trials...
Loading clinical trials...
A Placebo Controlled Study of the Impact on Insulin Sensitivity and Lipid Profile of Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers
Conditions
Interventions
Maraviroc
Maraviroc
Locations
1
United Kingdom
Chelsea and Westminster Hospital
London, London, United Kingdom
Start Date
May 1, 2008
Primary Completion Date
November 1, 2008
Completion Date
November 1, 2008
Last Updated
August 16, 2010
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
St Stephens Aids Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions